股票配资网-杠杆开户中航资本.平台简介-【东方资本】,股市财经推荐股票排名最新,组合选股条件怎么设置,可靠的炒股配资网站有哪些

Company news

It is a high-tech enterprise engaged in R & D, production and sales of minimally invasive medical devices

• 

  Xinxiang bio absorbable stent implanted in Kaifeng Central Hospital

  2020-09-01

  On July 25, Qin Lei, President of Kaifeng Central Hospital, successfully implanted a xinsorb bioabsorbable stent for a patient with coronary heart disease

• 

  Xinxiang bio absorbable coronary stent Investment Fair successfully held

  2020-09-02

  On April 25, Weigao endocardial consumables group held a business invitation meeting on the listing of xinsorb absorbable coronary stent with the theme of "heart returning to nature, auspicious Hua'an" at Weihaiwei building.

• 

  Xinsorb rapamycin eluting stent system

  2020-09-16

  Xinsorb rapamycin eluting stent system。It is a high-tech enterprise engaged in R & D, production and sales of minimally invasive medical devices

• 

  Introduction of Shandong Hua'an Biotechnology Co., Ltd

  2020-08-31

  Shandong Hua'an Biotechnology Co., Ltd. was established in February 2008, registered in Laicheng Industrial Zone, Jinan City, Shandong Province

• 

  Biodegradable coronary stents (xinsorb)

  2020-08-31

  "Biodegradable coronary stents (xinsorb)" is a project independently developed by our company. The core of the project is new material research and application technology

• 

  OCC 2020 ▏Launch of xinsorb absorbable coronary stent

  2020-08-31

  On May 30, the launch conference of xinsorb Xinxiang absorbable coronary stent was successfully held at the 14th Oriental cardiology Conference (OCC 2020)。

• 

  The company won the excellent enterprise award of the 7th China Innovation and entrepreneurship competition

  2020-08-31

  China Innovation and entrepreneurship competition is a national entrepreneurship competition with the theme of & quot; scientific and technological innovation

• 

  Rapamycin eluting stent system for bioabsorbable coronary artery

  2020-08-31

  Recently, the State Drug Administration approved the registration of "bio absorbable coronary rapamycin eluting stent system"……